Immunohistochemical differentiation between inflammatory linear verrucous epidermal nevus (ILVEN) and psoriasis

European Journal of Dermatology

Volumn 14, Issue 4, 2004, Pages 216-220

  Vissers, W H P M ^a   Muys, L ^a   Van Erp, P E J ^a   De Jong, E M G J ^a   Van De Kerkhof, P C M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

ILVEN; Immunohistochemistry; Psoriasis; T lymphocytes subsets

Indexed keywords

BIOCHEMICAL MARKER; CD161 ANTIGEN; CD2 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD45RA ANTIGEN; CD45RO ANTIGEN; CD8 ANTIGEN; CD94 ANTIGEN; CORTICOSTEROID; CYTOKERATIN 10; DITHRANOL; HLA DR ANTIGEN; INTERLEUKIN 2 RECEPTOR; KI 67 ANTIGEN; UNCLASSIFIED DRUG; VITAMIN D DERIVATIVE;

ADOLESCENT; ADULT; AGED; ARTICLE; CASE REPORT; CELL GROWTH; DIFFERENTIAL DIAGNOSIS; EPIDERMIS CELL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KERATINIZATION; MALE; NEVUS; PROTEIN EXPRESSION; PSORIASIS; QUANTITATIVE ANALYSIS; SKIN BIOPSY; SKIN DEFECT; SKIN INFLAMMATION; SYMPTOMATOLOGY; SYNDROME ILVEN; T LYMPHOCYTE SUBPOPULATION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATIN-10; KERATINS; MALE; MIDDLE AGED; NEVUS; PSORIASIS; SKIN NEOPLASMS; T-LYMPHOCYTE SUBSETS;

EID: 3543064222     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Cheesbrough MJ, Kilby PE. The inflammatory linear verrucous epidermal naevus-a case report. Clin Exp Dermatol 1978; 3: 293-8.
2. Altman J, Mehregan AH. Inflammatory linear verrucose epidermal nevus. Arch Dermatol 1971; 104: 385-9.
3. Rogers M, McCrossin I, Commens C. Epidermal nevi and the epidermal nevus syndrome. A review of 131 cases. J Am Acad Dermatol 1989; 20: 476-88.
4. Dupre A, Christol B. [Bilateral inflammatory linear verrucous epidermal nevus localized on the lip and with minimal histological lesions]. Ann Dermatol Venereol 1977; 104: 163-4.
5. Menni S, Restano L, Gianotti R et al. Inflammatory linear verrucous epidermal nevus (ILVEN) and psoriasis in a child? Int J Dermatol 2000; 39: 30-2.
6. de Jong E, Rulo HF, van de Kerkhof PC. Inflammatory linear verrucous epidermal naevus (ILVEN) versus linear psoriasis. A clinical, histological and immunohistochemical study. Acta Derm Venereol 1991; 71: 343-6.
7. Welch ML, Smith KJ, Skelton HG et al. Immunohistochemical features in inflammatory linear verrucous epidermal nevi suggest a distinctive pattern of clonal dysregulation of growth. Military Medical Consortium for the Advancement of Retroviral Research. J Am Acad Dermatol 1993; 29: 242-8.
8. Gatti S, Carrozzo AM, Orlandi A et al. Treatment of inflammatory linear verrucous epidermal naevus with calcipotriol. Br J Dermatol 1995; 132: 837-9.
9. de Mare S, van de Kerkhof PC, Happle R. Dithranol in the treatment of inflammatory linear verrucous epidermal nevus. Acta Derm Venereol 1989; 69: 77-80.
10. Nickoloff BJ. The immunologic and genetic basis of psoriasis. Arch Dermatol 1999; 135: 1104-10.
11. Gattlieb AB. Immunologic mechanisms in psoriasis. J Invest Dermatol 1990; 95: 18S-9S.
12. Krueger JG. The immunologic basis for the treatment of psoriasis with new biologic agents. J Am Acad Dermatol 2002; 46: 1-23.